ARCHIVES

FDA Grants Accelerated Approval to Imbruvica

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Concepts Of Eight New Biological Response Modifiers Program

July 3, 1981

Guest Commentary: Donald Berry Finds Fundamental Flaws In Data Pooling Plan.

November 16, 2007

Phase III PANORAMA-1 Trial Meets PFS Primary Endpoint

June 27, 2014

Sen. Dole Raps HEW Over Delays On Patent Requests

August 11, 1978

DCBD Board Okays Concept For New Cytogenetics RFA

August 3, 1984

FDA Staff Failed To Explain Approval Standards, Correct Misconceptions.

April 13, 2007